Vol. 10, Issue 7, Part B (2025)

Background: The veterinary pharmaceutical industry plays a crucial role in maintaining animal health and mitigating the economic impact of livestock diseases. Livestock also have serious implications on global food security. Understanding regulatory guidelines will assist countries to enhance global cooperation and address emerging challenges in animal health and welfare effectively.
Main body: Understanding the regulatory framework is essential for stakeholders involved in the development, approval, and monitoring of veterinary drugs, particularly in light of increasing incidences of livestock diseases such as foot and mouth disease, salmonellosis, and I.B.D by adhering to harmonized regulatory standards, countries can enhance global cooperation and address emerging challenges in animal health and welfare effectively. However, a drawback of increasing use of veterinary medicine is leading to hazards related to accumulation of drug residues, which is a big problem especially in livestock meant for human consumption. Potential health risks posed by these residues, their detection techniques are discussed. Recent veterinary drug approvals are also summarized, along with the available products in the market. Additionally, the paper delves into FDA regulations for veterinary feed and considerations in disease management.
Conclusion: This review discusses the regulatory frame work for veterinary pharmaceuticals overseen by regulatory bodies such as the CDSCO in India, EMA in the Europe and the FDA in the United States. Popular veterinary formulation is highlighted. Advanced techniques are discussed for diagnosing, treatment and prevention of animal diseases. On the contrary, increased use of veterinary drugs leads to residual accumulation, which poses a health threat for human consumption of livestock. Common drug residues and detection methods are also summarized. Sustainable methods for disease management are the need of the hour and there is scope for innovations in veterinary medicine.